Last reviewed · How we verify
LECITHIN
At a glance
| Generic name | LECITHIN |
|---|---|
| Drug class | Standardized Chemical Allergen [EPC] |
| Phase | FDA-approved |
Approved indications
- Cold Clammy Feet Relief
- Numbness of Limbs Relief
- Painful Calves Upon Walking Relief
- Muscular Weakness of Lower Extremities Relief
Common side effects
Key clinical trials
- CARNIVAL Study: Gut Flora Dependent Metabolism of Dietary CARNItine and Phosphatidylcholine and cardioVAscuLar Disease (EARLY_PHASE1)
- A Real World Study of Polyene Phosphatidylcholine Injection for the Prevention and Treatment of DILI in Patients With Malignant Hematological Diseases
- Child Health, Agriculture and Integrated Nutrition (NA)
- Temporary Inactivation of Strong Muscle Sensation to Improve Rehabilitation Interventions in SCI (PHASE1)
- Dose-Escalating Study of Pfs230D1 in Combination With R21 in Matrix-M in African Adults (PHASE1)
- Acute Effects of Alpha-glycerylphosphorylcholine (A-GPC) on Lower Body Muscular Performance. (NA)
- Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer (NA)
- Evaluate Pharmacokinetic/Pharmacodynamic and Safety/Tolerability of AYP-101 in Healthy Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- LECITHIN CI brief — competitive landscape report
- LECITHIN updates RSS · CI watch RSS